| Pharmaceutical•Biotech Companies are Catching Attention by Securing Growth Drivers Through Business Diversification, Expanding Areas to Showcase their Expertise.
| JNPMEDI Presents a New Business Model to Strengthen its Competitiveness as a Life Sciences RDC Company.
Despite a sluggish market, the pharmaceutical and biotech industry is accelerating its business diversification efforts. By diversifying business structures, companies can secure additional revenue streams and establish sustainable growth systems.
Notably, companies with specialized expertise are making significant strides. From startups to large pharmaceutical companies, business diversification is actively occurring, expanding capabilities into different areas. Approaches vary from introducing innovative business models to the market to entering different industries through mergers and acquisitions or launching new brands.
■ 'Game Changer' JNPMEDI Expands Business Areas and Reorganizes: Steps Toward Innovation
JNPMEDI, a medical data platform company, is focusing on business diversification and strengthening organizational capabilities. This is to enhance competitiveness as a life sciences RDC company that designs and provides customized solutions for all areas of pharmaceutical and biotech businesses.
Recently, JNPMEDI introduced a total digital medical business boosting solution, expanding its business areas. This solution offers comprehensive consulting for the commercialization of pharmaceuticals and medical devices. It is a new business model based on the self-developed Maven Clinical Cloud platform for clinical operations and data management. Its main feature is the integrated support for accelerating all fragmented business areas, from product planning, operational strategy development, regulatory approval, to licensing out.
In line with business diversification, JNPMEDI also promptly reorganized. The company recently formed the RDC team, a group of top experts in the pharmaceutical and biotech commercialization field. This new organization, operating under the CEO's leadership with a focus on customer success, assists clients in making optimal decisions and smoothly progressing projects at every stage of the pharmaceutical and medical device business, from business planning and investment connections to clinical trial operations, product commercialization, and post-market management. The team includes top industry experts, such as doctors, pharmacists, and nurses.
With significant business expansion, JNPMEDI is also launching its first large-scale recruitment drive. The company is conducting an open recruitment for new and experienced personnel across seven clinical operation roles within the Business Headquarters (GBP). On the 25th, JNPMEDI will host an open house event at its headquarters, featuring a recruitment briefing and mentoring program. Applications will be accepted starting from the 27th of this month, and interested individuals can apply via the official JNPMEDI website.
| Pharmaceutical•Biotech Companies are Catching Attention by Securing Growth Drivers Through Business Diversification, Expanding Areas to Showcase their Expertise.
| JNPMEDI Presents a New Business Model to Strengthen its Competitiveness as a Life Sciences RDC Company.
Despite a sluggish market, the pharmaceutical and biotech industry is accelerating its business diversification efforts. By diversifying business structures, companies can secure additional revenue streams and establish sustainable growth systems.
Notably, companies with specialized expertise are making significant strides. From startups to large pharmaceutical companies, business diversification is actively occurring, expanding capabilities into different areas. Approaches vary from introducing innovative business models to the market to entering different industries through mergers and acquisitions or launching new brands.
■ 'Game Changer' JNPMEDI Expands Business Areas and Reorganizes: Steps Toward Innovation
JNPMEDI, a medical data platform company, is focusing on business diversification and strengthening organizational capabilities. This is to enhance competitiveness as a life sciences RDC company that designs and provides customized solutions for all areas of pharmaceutical and biotech businesses.
Recently, JNPMEDI introduced a total digital medical business boosting solution, expanding its business areas. This solution offers comprehensive consulting for the commercialization of pharmaceuticals and medical devices. It is a new business model based on the self-developed Maven Clinical Cloud platform for clinical operations and data management. Its main feature is the integrated support for accelerating all fragmented business areas, from product planning, operational strategy development, regulatory approval, to licensing out.
In line with business diversification, JNPMEDI also promptly reorganized. The company recently formed the RDC team, a group of top experts in the pharmaceutical and biotech commercialization field. This new organization, operating under the CEO's leadership with a focus on customer success, assists clients in making optimal decisions and smoothly progressing projects at every stage of the pharmaceutical and medical device business, from business planning and investment connections to clinical trial operations, product commercialization, and post-market management. The team includes top industry experts, such as doctors, pharmacists, and nurses.
With significant business expansion, JNPMEDI is also launching its first large-scale recruitment drive. The company is conducting an open recruitment for new and experienced personnel across seven clinical operation roles within the Business Headquarters (GBP). On the 25th, JNPMEDI will host an open house event at its headquarters, featuring a recruitment briefing and mentoring program. Applications will be accepted starting from the 27th of this month, and interested individuals can apply via the official JNPMEDI website.